Clinical Trials Browser

INDUSTRY × Melanoma × glembatumumab vedotin × Clear all

NCT02302339 2019-09-06

A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced Melanoma

Phase 2 Terminated

132 enrolled 16 charts

Melanoma, Skin Neoplasms